Environmental, Social And Governance Report

Overview

The report covers Hengrui Pharma's 2024 group-wide ESG performance across the company and its subsidiaries. It describes Board-led ESG governance and a double materiality assessment, while reporting comprehensive energy consumption of 72,888 tonnes of standard coal and total Scope 1 plus Scope 2 GHG emissions of 257,897.24 tonnes of CO2 equivalent. The workforce totaled 20,238 employees, with women representing 44.9% of employees and 11.1% of the board. It also highlights broad compliance training, employee development and expanded access to medicines.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 27 March 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview